THE ROLE OF INTERLEUKIN-2 IN CANCER-THERAPY

被引：0
作者：
KOHLER, PC
SONDEL, PM
机构：
[1] UNIV WISCONSIN,DEPT HUMAN ONCOL,MADISON,WI 53792
[2] UNIV WISCONSIN,DEPT PEDIAT,MADISON,WI 53792
[3] UNIV WISCONSIN,DEPT GENET,MADISON,WI 53792
来源：
CANCER SURVEYS | 1989年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：861 / 873
页数：13
相关论文
共 62 条
  • [21] LANIER LL, 1983, J IMMUNOL, V131, P1789
  • [22] LIFSON J, 1986, J BIOL RESP MODIF, V5, P61
  • [23] LOTZE MT, 1984, J BIOL RESP MODIF, V3, P475
  • [24] HIGH-DOSE RECOMBINANT INTERLEUKIN-2 IN THE TREATMENT OF PATIENTS WITH DISSEMINATED CANCER - RESPONSES, TREATMENT-RELATED MORBIDITY, AND HISTOLOGIC-FINDINGS
    LOTZE, MT
    CHANG, AE
    SEIPP, CA
    SIMPSON, C
    VETTO, JT
    ROSENBERG, SA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (22): : 3117 - 3124
  • [25] LOTZE MT, 1985, J IMMUNOL, V135, P2865
  • [26] RECOMBINANT INTERLEUKIN-2 DIRECTLY AUGMENTS THE CYTOTOXICITY OF HUMAN-MONOCYTES
    MALKOVSKY, M
    LOVELAND, B
    NORTH, M
    ASHERSON, GL
    GAO, L
    WARD, P
    FIERS, W
    [J]. NATURE, 1987, 325 (6101) : 262 - 265
  • [27] MALKOVSKY M, 1987, Blood Reviews, V1, P254, DOI 10.1016/0268-960X(87)90027-0
  • [28] INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELL THERAPY OF SOLID TUMORS - ANALYSIS OF TOXICITY AND MANAGEMENT GUIDELINES
    MARGOLIN, KA
    RAYNER, AA
    HAWKINS, MJ
    ATKINS, MB
    DUTCHER, JP
    FISHER, RI
    WEISS, GR
    DOROSHOW, JH
    JAFFE, HS
    ROPER, M
    PARKINSON, DR
    WIERNIK, PH
    CREEKMORE, SP
    BOLDT, DH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) : 486 - 498
  • [29] MERTELSMANN R, 1984, J BIOL RESP MODIF, V4, P483
  • [30] SELECTIVE INVITRO GROWTH OF T-LYMPHOCYTES FROM NORMAL HUMAN BONE MARROWS
    MORGAN, DA
    RUSCETTI, FW
    GALLO, R
    [J]. SCIENCE, 1976, 193 (4257) : 1007 - 1008
1234567